Insider · CIK 0001820836

Jacobs John C

Reports to the SEC for 2 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001820836

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+150K sh	—	—	264,130
2026-03-03	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−69.3K sh	$9.49	−$658K	225,680
2026-03-03	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−150K sh	—	—	300,333
2026-03-02	NVAXNOVAVAX INC · Non-Statutory Stock Option NQA Award	Director, President and CEO	AAward	+552K sh	—	—	551,500
2026-03-02	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+368K sh	—	—	367,500
2026-03-02	NVAXNOVAVAX INC · Non-Statutory Stock Option NQA Award	Director, President and CEO	AAward	+552K sh	$9.09	+$5.01M	551,500
2026-03-01	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.3K sh	—	—	264,130
2026-03-01	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−38.5K sh	$10.14	−$390K	225,680
2026-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.3K sh	—	—	0
2026-01-23	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.2K sh	—	—	219,929
2026-01-23	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−39.1K sh	$9.17	−$359K	180,797
2026-01-23	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.2K sh	—	—	0
2025-03-03	NVAXNOVAVAX INC · 2025 Non-statutory Stock Option NQA Award	Director, President and CEO	AAward	+676K sh	$7.87	+$5.32M	676,000
2025-03-03	NVAXNOVAVAX INC · 2025 Restricted Stock Units RSUA Award	Director, President and CEO	AAward	+451K sh	—	—	450,500
2025-03-01	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.3K sh	—	—	175,183
2025-03-01	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−38.5K sh	$8.33	−$320K	136,732
2025-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.3K sh	—	—	166,666
2025-01-23	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.2K sh	—	—	130,722
2025-01-23	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−38.9K sh	$9.55	−$371K	91,849
2025-01-23	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.2K sh	—	—	83,197
2024-03-01	NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+500K sh	—	—	500,000
2024-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2024-01-23	NVAXNOVAVAX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.2K sh	—	—	83,197
2024-01-23	NVAXNOVAVAX INCF Tax Payment	Director, President and CEO	FTax Payment	−40.1K sh	$4.26	−$171K	43,104
2024-01-23	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.2K sh	—	—	166,393
2023-01-23	NVAXNOVAVAX INC · Stock Option (Right to buy)A Award	Director, President and CEO	AAward	+291K sh	—	—	290,700
2023-01-23	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+250K sh	—	—	249,590
2022-08-15	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+40K sh	$8.22	+$329K	40,000
2022-08-15	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−39.1K sh	$51.05	−$2M	909
2022-08-15	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−909 sh	$51.76	−$47.1K	0
2022-08-15	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−40K sh	—	—	114,751
2022-06-15	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+15K sh	$8.22	+$123K	15,000
2022-06-15	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−14.2K sh	$45.38	−$644K	800
2022-06-15	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−800 sh	$46.13	−$36.9K	0
2022-06-15	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−15K sh	—	—	154,751
2022-06-13	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+25K sh	$8.22	+$206K	25,000
2022-06-13	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−9,803 sh	$43.63	−$428K	15,197
2022-06-13	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−15.2K sh	$44.53	−$677K	0
2022-06-13	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−25K sh	—	—	169,751
2022-03-16	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+15K sh	$8.22	+$123K	15,000
2022-03-16	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−15K sh	$45.32	−$680K	0
2022-03-16	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−15K sh	—	—	194,751
2022-03-14	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+25K sh	$8.22	+$206K	25,000
2022-03-14	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−12.5K sh	$42.06	−$524K	12,544
2022-03-14	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−11.6K sh	$42.66	−$495K	930
2022-03-14	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−930 sh	$43.47	−$40.4K	0
2022-03-14	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−25K sh	—	—	209,751
2022-01-04	HRMYHarmony Biosciences Holdings, Inc.M Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	+18.1K sh	$8.22	+$148K	18,053
2022-01-04	HRMYHarmony Biosciences Holdings, Inc.S Sale	Director, PRESIDENT, CEO	SSale	−18.1K sh	$45.15	−$815K	0
2022-01-04	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionM Exercise/Conversion	Director, PRESIDENT, CEO	MExercise/Conversion	−18.1K sh	—	—	234,751

Recent filings

Accepted (ET)
Mar 94/A
Jacobs John C0001104659-26-025363
SEC(opens sec.gov)
Mar 54
Jacobs John C0001104659-26-023726
SEC(opens sec.gov)
Mar 34
Jacobs John C0001104659-26-023074
SEC(opens sec.gov)
Jan 264
Jacobs John C0001104659-26-006721
SEC(opens sec.gov)
Mar 54
Jacobs John C0001593968-25-000304
SEC(opens sec.gov)
Mar 44
Jacobs John C0001593968-25-000286
SEC(opens sec.gov)
Jan 274
Jacobs John C0001593968-25-000137
SEC(opens sec.gov)

Companies

Address

21 FIRSTFIELD ROAD

GAITHERSBURG, MD, 20878